Fast optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo
Dr. Hailong He, Group leader at Technical University of Munich, presents his work on fast high-resolution optoacoustic imaging in human melanoma. He shows how 3D imaging of vascular characteristics in skin lesions could allow diagnostic insights not available by conventional visual inspection.
Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
Dr. Isabel Quiros Gonzalez, Head of the Histopathology Core at the University of Oviedo and previously with Cancer Research UK Cambridge Institute, outlines her work using MSOT (multispectral optoacoustic tomography) to assess response to a vascular-disruptive treatment in a preclinical breast cancer model.
Novel genetically encoded contrast agents for preclinical optoacoustic imaging
Dr André Stiel, group leader at the Institute of Biological Medical Imaging at the Helmholtz Zentrum in Munich
Optoacoustics and Optical: Complementary Modalities for Molecular Imaging
Judith Weber PhD, University of Cambridge
Alexa Hasenbach, University of MĂĽnster
Dr. Sheryl Roberts, Memorial Sloan Kettering
MSOT and MRI – Complementary Modalities for Pre-clinical Imaging
Dr. Mark ‘Marty’ Pagel, Department of Cancer Systems Imaging, MD Anderson Cancer Center
Innovations in Optoacoustic Imaging for Preclinical and Clinical Research
Neal Burton, PhD, Team Lead Applications, iThera Medical
Imaging Tumor Function and Response with Optoacoustics
Dr. Katja Haedicke, iThera Medical
Liver Injury and Tumor Metastasis Imaging with MSOT
Prof Dr Shuizhu Wu, State Key Laboratory of Luminescent Materials & Devices, College of Materials Science & Engineering, South China University of Technology
Multimodal cell tracking by combining gold nanorods and reporter genes
Dr Raphael Levy and
Dr Antonius Plagge, University of Liverpool, UK
Imaging tumor vascularization in high resolution with raster-scanning optoacoustic mesoscopy (RSOM)
Dr Katja Haedicke, Memorial Sloan Kettering Cancer Center, New York